Therapeutic Immunosuppression

1. Calcineurin-targeted inhibition of immune reactivity; L. Kung, P.F. Halloran. 2. Experimental immunosuppressive agents; J. Klupp, R. Morris. 3. Polyclonal and monoclonal antibodies; L. Chatenoud. 4. Cytokines and their receptors as therapeutic targets; P. Nickerson. 5. Novel strategies using MHC peptides; C.C. Magee, M.H. Sayegh. 6. Costimulatory blockade as a therapeutic regimen for prolonging allograft survival and inducing tolerance: an overview of recent research; M.M. Hamawy, et al. 7. Oral tolerance; H.L. Weiner. 8. Hematopoietic stem cell chimerism and tolerance induction; H. Shirwan, S.T. Ildstad. 9. Strategies to promote tolerance induction using dendritic cells; A.W. Thomson, L. Lu. 10. Gene therapy for autoimmune disease and transplantation; C.H. Evans, et al. 11. Local immunosuppression: the eye; J.W. Streilein, A.W. Taylor. 12. Topical skin immune system response modifiers; J.D. Bos. 13. Local immunosuppression: the lung; A.T. Iacono, et al. 14. Therapy of autoimmune connective tissue diseases; T.M. Wright, D.P. Ascherman. 15. Immunotherapy for allergic diseases; D. Umetsu, R.H. DeKruyff. 16. Therapeutic strategies for xenotransplantation; J.L. Platt. 17. Medical complications of immunosuppression; J. McCauley, R. Shapiro. 18. Neurological complications of immunosuppression; B.H. Eidelman, R. Shapiro. 19. Infectious complications of immunosuppression; S. Kusne, R. Shapiro. Index.